By Noah Weiland and Sharon LaFraniere The Food and Drug Administration on Thursday authorized third doses of Pfizer-BioNTech’s and Moderna’s coronavirus vaccines for some people with weakened immune systems, giving physicians more leeway to protect...
With daily reports of breakthrough infections and the rise of the Delta variant, vaccinated people may need to take a few more precautions. Here’s what you need to know. By Tara Parker-Pope As the Delta variant spreads among the unvaccinated, many fully...
Scientific understanding of the coronavirus variant is changing quickly. Here’s a recap of the most important findings. By Apoorva Mandavilli Citing new evidence that vaccinated Americans with so-called breakthrough infections can carry as much coronavirus...
By G. Owen Schaefer MoreNew Online Views 13,358 Citations 0112Comments 3ViewpointAugust 12, 2021 Making Vaccines Available to Other Countries Before Offering Domestic Booster Vaccinations G....
By Sameer S. Kadri, MD The implications of a surge in COVID-19 cases due to the Delta variant of SARS-CoV-2 on rural areas of the US and its health care safety net warrant careful and prompt appraisal. In early July, 2 referral hospitals in Missouri that receive...
— Most patients on active treatment remained seropositive at 4 months by Mike Bassett Cancer patients on active treatment achieved sustained responses to the Pfizer/BioNTech COVID-19 vaccine, though at reduced antibody levels versus healthy controls, according to...
Below you can download the I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19 with guidance on the timing and doses of each component medication. Further below please find more information on the I-MASK+ Protocol. The I-MASK+ Protocol...
Duke Clinical Research Institute recently announced the elite research center is participating in the latest National Institute of Health (NIH) Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), which focuses on repurposed, generic therapies...
TrialSite has written extensively about the need for antiviral-type, early-care treatments targeting COVID-19. Early in the pandemic, this platform tracked numerous studies involving repurposed drugs such as ivermectin, favipiravir, hydroxychloroquine, and more. By...
By NATASHA KORECKI and TINA SFONDELES Not long ago, just talking about the idea of vaccine mandates made the White House skittish. As president-elect, JOE BIDEN said Americans would not be required to get vaccinated, and he said in April it would...
Delta won’t be the last variant. What will the next ones bring?By Dhruv Khullar In 1988, Richard Lenski, a thirty-one-year-old biologist at UC Irvine, started an experiment. He divided a population of a common bacterium, E. coli, into twelve flasks. Each...
Solidarity PLUS trial for promising drugs will roll out in 52 countries, an unprecedented global collaboration for COVID-19 R&D The World Health Organization (WHO) has announced the next phase in its Solidarity trial: Solidarity PLUS will enroll hospitalized...
Serious coronavirus infections among vaccinated people have been relatively rare since the start of the vaccination campaign, a New York Times analysis of data from 40 states and Washington, D.C., shows. Fully vaccinated people have made up as few as 0.1 percent of...
“The hardship comes when you run to your farm supply store and they don’t have [ivermectin] on the shelves anymore because of all of this.” BY SOFIA ANDRADE Folks who are skeptical of masks and vaccines but still believe in COVID have turned to a variety of...
As breakthrough infections rise from the highly contagious Delta variant of the coronavirus, the precise risk to the fully vaccinated may be confusing. Northwestern Medicine experts explain why the number of breakthrough infections from the Delta variant are going up,...